Kwality Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	340.51	120.2	22.58	30.7	91.35	58.09
Short-Term Investments	-	27.35	36.86	42.94	38.16	44.38
Cash & Short-Term Investments	340.51	147.55	59.44	73.63	129.51	102.46
Cash Growth	338.74%	148.25%	-19.28%	-43.14%	26.40%	110.14%
Accounts Receivable	1,635	1,543	1,144	716.94	691.31	357.11
Other Receivables	128.62	127.94	163.82	68.96	88.01	-
Receivables	1,764	1,671	1,308	785.91	779.32	357.11
Inventory	838.39	834.66	783.87	863.15	533.6	307.84
Prepaid Expenses	-	-	-	-	-	0.9
Other Current Assets	258.24	184.57	275.9	349.31	835.76	290.69
Total Current Assets	3,201	2,838	2,427	2,072	2,278	1,059
Property, Plant & Equipment	1,421	1,440	1,391	1,348	1,039	594.21
Long-Term Investments	-	-	-	9.32	7.82	0.56
Other Intangible Assets	16.22	17.07	-	-	-	-
Long-Term Deferred Tax Assets	6.81	16.15	0.25	-	-	0.38
Other Long-Term Assets	131.54	161.88	124.4	107.12	81.08	8.5
Total Assets	4,776	4,473	3,942	3,536	3,406	1,663
Accounts Payable	582.95	557.93	443.17	351.92	345.15	262.15
Accrued Expenses	2.11	12.73	26.24	8.48	5.58	19.61
Short-Term Debt	963.91	973.26	785.59	629.61	337.23	164.55
Current Portion of Long-Term Debt	-	-	-	-	91.8	65.09
Current Income Taxes Payable	40.61	59.31	65.21	64.84	410	58
Other Current Liabilities	116.66	91.82	198.29	204.6	205.1	213.51
Total Current Liabilities	1,706	1,695	1,519	1,259	1,395	782.91
Long-Term Debt	140.5	151.19	195.6	273.03	202.88	182.64
Pension & Post-Retirement Benefits	3.82	2.52	2.16	9.03	7.53	6.78
Long-Term Deferred Tax Liabilities	-	-	-	4.11	2.75	-
Other Long-Term Liabilities	41.4	0	-	-	-	91.8
Total Liabilities	1,892	1,849	1,716	1,546	1,608	1,064
Common Stock	103.76	103.76	103.76	103.76	103.76	103.76
Additional Paid-In Capital	-	84.68	84.68	84.68	-	84.68
Retained Earnings	-	2,444	2,046	1,809	1,700	414.27
Comprehensive Income & Other	2,797	7.71	7.63	8	8.04	8.82
Total Common Equity	2,901	2,640	2,242	2,005	1,811	611.53
Minority Interest	-16.59	-16.52	-16.28	-14.47	-13.55	-13.02
Shareholders' Equity	2,885	2,624	2,226	1,991	1,798	598.51
Total Liabilities & Equity	4,776	4,473	3,942	3,536	3,406	1,663
Total Debt	1,104	1,124	981.19	902.64	631.92	412.28
Net Cash (Debt)	-763.9	-976.9	-921.75	-829	-502.41	-309.82
Net Cash Per Share	-73.67	-94.15	-88.83	-79.89	-48.42	-29.86
Filing Date Shares Outstanding	10.38	10.38	10.38	10.38	10.38	10.38
Total Common Shares Outstanding	10.38	10.38	10.38	10.38	10.38	10.38
Working Capital	1,494	1,143	908.39	812.54	883.33	276.09
Book Value Per Share	279.50	254.48	216.08	193.25	174.58	58.94
Tangible Book Value	2,885	2,623	2,242	2,005	1,811	611.53
Tangible Book Value Per Share	277.94	252.83	216.08	193.25	174.58	58.94
Land	-	-	-	-	-	10.58
Buildings	-	577.85	519.84	281.53	228.11	214.88
Machinery	-	1,515	1,357	1,272	966.75	582.46
Construction In Progress	-	-	-	142.92	121.49	28.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.